Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liquorice nanogel is a topical botanical formulation containing extracts from the roots of *Glycyrrhiza glabra* (liquorice) delivered via a nanogel system. Developed by researchers at Al-Azhar University, it is primarily investigated as an adjunctive treatment for Stage III periodontitis. The formulation leverages the antimicrobial and anti-inflammatory properties of liquorice constituents, such as glycyrrhizin and glabridin, to target periodontal pathogens like *Porphyromonas gingivalis* and reduce local inflammation. The nanogel delivery system is intended to provide sustained release of the active compounds within the periodontal pocket, improving therapeutic efficacy compared to conventional formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liquorice nanogel.